BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, BCR-ABL triggers tyrosine phosphorylation and hence stabilization and activation of β-catenin [39], which enhances the self-renewal and leukemic potential of CML stem/progenitors cells [69], [70].